Search Results 141-150 of 16475 for Pulmonary hypertension
Preliminary evidence suggests that ambrisentan is safe and effective in patients with portopulmonary hypertension. The goal of therapy for these patients is to ...
Learn about the research of Charles D. Burger, M.D., a pulmonary medicine specialist focused on pulmonary hypertension and lymphangioleiomyomatosis.
Treatment Patterns in Patients With Incident Pulmonary Hypertension: Real-World Data From the Pulmonary Hypertension Association Registry. Chest. 2026 Apr ...
Burger, M.D., presents on the approach to pulmonary arterial hypertension in the Advanced Heart Failure Grand Rounds series. Nov. 05, 2019. Robotic ...
Frantz's research includes defining best strategies for management of chronic thromboembolic pulmonary hypertension. Focus areas. Pathophysiology of pulmonary ...
Clinical Trials · A Study To Assess Whether Macitentan Delays Disease Progression In Children With Pulmonary Arterial Hypertension (PAH) · More about research at ...
... hypertension, Interstitial lung disease, Pulmonary fibrosis, Hepatopulmonary syndrome, Pulmonary valve disease. Show more areas of focus for Kelly M ...
High blood pressure in the lungs, also called pulmonary hypertension. This condition causes the blood vessels in the lungs to become stiff and narrow. It ...
For 30 years, Pat had known he could one day be diagnosed with pulmonary hypertension, high blood pressure that affects the arteries in the lungs and the right ...
The purpose of this study is to evaluate the prevalence and effect of frailty in patients referred to pulmonary hypertension (PH) clinic at our institution.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.